Observational studyBMC microbiology2026
The similarity between microbiota of gut and pancreatic necrotic drainage fluid in infected pancreatic necrosis and its potential diagnostic value: a prospective observational cohort study.
Observational study in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundInfected pancreatic necrosis (IPN) is a major determinant of mortality in acute necrotizing pancreatitis (ANP). Although gut bacterial translocation has been proposed as a key mechanism, direct evidence based on paired profiling of gut and pancreatic necrotic microbiota remains limited. This study aimed to compare microbial signatures across gut and extra-intestinal sites in ANP and to explore whether gut microbiota–based features may help identify IPN.
methodsIn this prospective observational cohort, 22 consecutive ANP patients undergoing the first minimally invasive intervention were enrolled (IPN, n = 16; sterile pancreatic necrosis [SPN], n = 6). Stool, pancreatic necrotic drainage fluid, peripheral blood, and deep sputum were collected at the first intervention and analyzed using SMRT full-length 16 S rRNA gene sequencing. The similarity between the gut microbiota and microbiota of extra-intestinal sites was assessed using shared amplicon sequence variants (ASVs) and beta-diversity distances. A genus-level random forest classifier based on gut microbiota profiles was evaluated using internal nested, stratified k-fold cross-validation.
resultsGut microbiota composition differed between IPN and SPN, characterized by enrichment of opportunistic pathogens (e.g., Escherichia coli) and depletion of potentially beneficial bacteria (e.g., Akkermansia muciniphila) in IPN. Both shared-ASV and beta-diversity analyses indicated higher similarity between gut microbiota and microbial signatures detected in pancreatic necrotic drainage fluid, blood, and deep sputum in IPN compared with SPN. In IPN, the proportion of shared ASVs was highest between gut and pancreatic necrotic drainage fluid (29.2%), followed by gut and blood (21.7%), and gut and lung (4.3%). The random forest classifier achieved an area under the receiver operating characteristic curve of 0.91 based on internal cross-validation, indicating potential discriminative ability for IPN.
conclusionsIPN was associated with gut dysbiosis and increased similarity between gut microbiota and microbial signatures detected at extra-intestinal sites, most prominently in pancreatic necrotic drainage fluid. A gut microbiota–based classifier showed potential discriminative ability for IPN under internal nested cross-validation, but these exploratory findings require confirmation in larger independent cohorts and further mechanistic investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.